Not investment advice.Read full disclaimer
Continue with finqOS
Side-by-side valuation, growth, and profitability metrics against the closest competitors.
14-day free trial · No credit card required
52W Range
Volume
Mkt Cap
P/E
Div Yield
Publicly traded Gland Pharma Limited (GLAND.NS) competitors and peer companies. Compare valuation, revenue growth, margins, and profitability against Ipca Laboratories Limited, Ipca Laboratories Limited, Ajanta Pharma Limited, Ajanta Pharma Limited, J. B. Chemicals & Pharmaceuticals Limited, and more.
| Ticker | Company | Market Cap |
|---|---|---|
| IPCALAB.BO | Ipca Laboratories Limited | $424.6B |
| IPCALAB.NS | Ipca Laboratories Limited | $421.9B |
| AJANTPHARM.NS | Ajanta Pharma Limited | $418.4B |
| AJANTPHARM.BO | Ajanta Pharma Limited | $414.1B |
| JBCHEPHARM.NS | J. B. Chemicals & Pharmaceuticals Limited | $369.6B |
| JBCHEPHARM.BO | J. B. Chemicals & Pharmaceuticals Limited | $366.7B |
| MEDANTA.BO | Global Health Limited | $356.0B |
| MEDANTA.NS | Global Health Limited | $353.2B |
| PFIZER.BO | Pfizer Limited | $202.6B |
| PFIZER.NS | PFIZER.NS | — |